1886P Pembrolizumab and denosumab in clear cell renal cell carcinoma (ccRCC): A phase II trial (KeyPAD, ANZUP1601)
| Autor: | Gedye, C., Harris, C.A., Stockler, M.R., Morris, M., Ferguson, T., Goh, J.C.H., Martin, A., Underhill, C.R., Pook, D., Krieger, L.E.M., Kichenadasse, G., Joshi, A.J., Subramaniam, S., Zebic, D.S., Zhang, A., Joshua, A.M., Toner, G.C., Vasey, P.A., Prithviraj, P., Davis, I.D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1014-S1014 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|